Glaucoma Treatment Market Size, Share, Analysis, Industry Report and Forecast 2021-2027

 The global glaucoma treatment market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period (2021-2027). With the increasing prevalence of glaucoma among the geriatric population the demand for its treatment has been an increase. Therefore, the increasing approvals of the drugs for the treatment of glaucoma diseases are offering opportunities for market growth. For instance, in February 2021, Bausch health companies Inc., and Nicox, an ophthalmology company had received US FDA approval for VYZULTA, a latanoprostene bunod ophthalmic solution. This drug is for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma in the US. VYUZULTA is an important drug used for the treatment of glaucoma and now it is approved in nine markets including Canada, Argentina, Colombia, Taiwan, Hong Kong, Mexico, South Korea, Ukraine, and the US.

To Request a Sample of our Report on Glaucoma Treatment Market:  https://www.omrglobal.com/request-sample/glaucoma-treatment-market

Further, in July 2019, Allergan Plc, a pharmaceutical company, has announced that the US Food and Drug Administration (FDA) has accepted the new drug application (NDA) for Bimatoprost sustained-release (SR). The NDA is focused on the promising outcomes of the ARTEMIS phase 3 trials, and it shows our continued commitment to developing alternative therapies for glaucoma patients.  Apart from it, in September 2020, Aerie Pharmaceuticals Inc., an ophthalmic pharmaceutical company focused on drugs for the treatment of eye-related disease, has announced that FDA has approved a new drug application (NDA), and AR-15512 eye drop for dry eye. Thus, the huge US FDA approvals for glaucoma treatment and various initiatives in drugs by the companies for the treatment of disease are driving the global market growth during the forecast period.

(Get 15% Discount on Buying this Report)

A full Report of Glaucoma Treatment Market is Available at:  https://www.omrglobal.com/industry-reports/glaucoma-treatment-market

Market Coverage

·                  The market number available for – 2020-2027

·                  Base year- 2020

·                  Forecast period- 2021-2027

Segment Covered- 

·                  By Disease Indication

·                  By Distribution Channel 

·                  By Drug Class

Regions Covered-

·                  North America

·                  Europe

·                  Asia-Pacific

·                  Rest of the World

·                  Competitive Landscape-Aeries Pharmaceuticals, Inc., Bausch & Lomb Inc., Inotek Pharmaceuticals, Novartis AG, Merck & Co., Pfizer Inc., Teva Pharmaceuticals Industries, Hoya Corp., and others

Recent Strategies initiatives in the Global Glaucoma Treatment Market:

·                  In November 2019, Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the treatment of patients with open-angle glaucoma, and other eye diseases announced that it has acquired AVizorex Pharma, S.L. (AVX). This acquisition was done for $10 million. This has expanded the drug portfolio of the company for the treatment of eye disease.

·                  In October 2018, Carl Zeiss Meditec has acquired IanTech, the company focused on technology solutions for micro-interventional cataract surgery. The company has enhanced the portfolio of surgical ophthalmology solutions, and this acquisition has assisted the company to provide ophthalmology solutions across the globe. 

Global Glaucoma Treatment Market Report Segment

By Disease Indication

·                  Closed Angle Glaucoma (CAG)

·                  Open-Angle Glaucoma (OAG)

·                  Secondary Glaucoma

·                  Congenital Glaucoma

By Distribution Channel

·                  Hospital Pharmacy

·                  Retail Pharmacy

·                  Online Pharmacy

By Drug Class

·                  Prostaglandin Analogues 

·                  Alpha Agonist 

·                  Cholinergic 

·                  Beta-Blockers

·                  Carbonic Anhydrase Inhibitors

Regional Analysis

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  China

·                  India

·                  Japan

·                  South Korea

·                  Rest of Asia-Pacific 

Rest of the World

·                  Latin America 

·                  Middle East & Africa

Company Profiles 

·                  Aerie Pharmaceuticals, Inc.

·                  Akorn, Inc.

·                  Allergan Plc

·                  Bausch & Lomb Pvt. Ltd.

·                  Bayer AG

·                  Carl Zeiss AG

·                  F. Hoffmann-La Roche, Ltd.

·                  HOYA Corp.

·                  InotekCorp.

·                  Ivantis, Inc.

·                  Johnson & Johnson Vision Care, Inc.

·                  Merck & Co., Inc.

·                  Novartis AG

·                  Pfizer, Inc.

·                  Regeneron Pharmaceuticals, Inc.

·                  Sanofi S.A.

·                  Santen Pharmaceuticals Co., Ltd.

·                  Teva Pharmaceuticals Industries, Ltd.

·                  Topcon Corp.

·                  Valeant Pharmaceuticals International, Inc.

Reasons to Buying From us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/glaucoma-treatment-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

 

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more